Synlett 2019; 30(08): 943-946
DOI: 10.1055/s-0037-1612413
letter
© Georg Thieme Verlag Stuttgart · New York

Ionic-Liquid-Supported 1,3-Dimethylimidazolidin-2-one: Application as a Reusable Halogenation Reagent

Shinichi Koguchi*
Department of Chemistry, School of Science, Tokai University, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 259-1292, Japan, Email: koguchi@tokai-u.jp
,
Yuga Shibuya
,
Yusuke Igarashi
,
Haruka Takemura
› Author Affiliations
This work was supported by Tokai University General Research Organization Grant.
Further Information

Publication History

Received: 25 January 2019

Accepted after revision: 19 February 2019

Publication Date:
19 March 2019 (online)


Abstract

We describe the synthesis of ionic-liquid-supported 1,3-dimethylimidazolidin-2-one, together with the halogenation of alcohols in a reaction system in which this reagent is combined with oxalyl chloride. A new method was established that does not require additives such as bases, and which permits the ready isolation and purification of the product. Good conversions were obtained, and good reusability of the reagent was observed.

Supporting Information

 
  • References and Notes

  • 2 Akiyama A, Hanamura H, Imatomi S, Yamada S, Itou H, Kondou H, Maeshima Y. JP 2018024818, 2018
  • 4 Disadee W, Watanabe T, Ishikawa T. Synlett 2003; 115
  • 7 Cao H, McNamee L, Alper H. J. Org. Chem. 2008; 73: 3530
  • 10 Chlorination of Alcohols (Table 2); General ProcedureThe solution of ionic-liquid-supported DMI 7 (2.2 mmol) in [bmim]PF6 (2 mL) was added to oxalyl chloride (2.0 mmol), and the mixture was stirred at 60 °C for 2 h. The mixture was then added to the appropriate alcohol (1.5 mmol), and the resulting mixture was stirred at r.t. overnight. Finally, the mixture was extracted with hexane 10 mL x 3, and the organic layer was concentrated.1-(2-hydroxyethyl)imidazolidin-2-one (2)The solution of 2-((2-aminoethyl) amino) ethanol (6.24g, 60mmol) in ethylene glycol (4 ml) was added to ureal (3.60g, 60 ml). The mixture was stirred at 130 °C for 24 h. The mixture extracted with ethyl acetate, and organic layer was washed with H2O, dried (MgSO4) and evaporated. The product was isolated by silica gel column chromatography to give the title compound 2 (6.94 g, 89%) as white solid; mp 45 °C. 1H NMR (500 MHz, CDCl3): δ =3.30–3.77 (9H, m), 5.80 (1H, s). 13C NMR (CDCl3) δ = 38.4, 46.0, 46.3, 60.2, 164.0. HRMS (APCI): m/z [M + H]+ calcd for C5H11N2O2, 131.08205; found: 131.08390.1-(2-chloroethyl)imidazolidin-2-one (3)The solution of 1-(2-hydroxyethyl) imidazolidin-2-one (5.07g, 39.1mmol) in chloroform (10 ml) was added to thionyl chloride (5.70ml, 78.2mmol). The mixture was stirred at 50 °C for 3 h. The mixture was evaporated, and the product was isolated by silica gel column chromatography to give the title compound 3 (5.50 g, 95%) as white solid; mp 85–88 °C. 1H NMR (500 MHz, CDCl3): δ = 3.45–3.64 (8H, m), 5.60 (1H, s). 13C NMR (CDCl3) δ = 38.3, 42.5, 45.6, 46.0, 163.0. HRMS (APCI): m/z [M + Na]+ calcd for C5H9ClN2NaO, 171.03011; found: 170.03091.1-(2-chloroethyl)-3-methylimidazolidin-2-one (4)The solution of 1-(2-chloroethyl) imidazolidin-2-one (4.00g, 26mmol) in THF (56 ml) was added to sodium hydride (1.86g, 45mmol) at 0 °C. And then the mixture was added to iodomethane (3.4ml, 53.8mmol) and stirred at room temperature for 24 h. The mixture extracted with chloroform, and organic layer was washed with H2O, dried (MgSO4) and evaporated. The product was isolated by silica gel column chromatography to give the title compound 3 (4.03 g, 92%) as yellow liquid. 1H NMR (500 MHz, CDCl3): δ = 2.80 (3H, s), 3.32–3.63 (8H, m). 13C NMR (CDCl3) δ = 31.2, 42.5, 43.5, 45.0, 46.3, 161.2. HRMS (APCI): m/z [M + H]+ calcd for C6H12ClN2O, 163.06382; found: 163.06851.1-methyl-3-(2-(3-methyl-2-oxoimidazolidin-1-yl)ethyl)-1H-imidazol-3-ium chloride (5)The solution of 1-(2-chloroethyl)-3-methylimidazolidin-2-one (4.00 g, 24.6mmol) in toluene (30 ml) was added to 1-methylimidazole (2.02g, 24.4 ml). The mixture was stirred at 110 °C for 24 h. The mixture was washed with hexane and evaporated to give the title compound 5 (5.11 g, 85%) as yellow liquid. 1H NMR (500 MHz, DMSO): δ = 2.59 (3H, s), 7.13 (1H, s), 3.15–3.88 (6H, m), 3.88 (3H, s), 4.37 (2H, m), 7.77 (1H, s), 7.86 (1H, s), 9.47 (1H, s). 13C NMR (CDCl3) δ = 31.4, 36.2, 42.7, 44.7, 44.9, 47.3, 123.1, 123.9, 137.3, 161.2. HRMS (APCI): m/z [M]+ calcd for C10H17N4O, 209.1402; found: 209.14283.1-methyl-3-(2-(3-methyl-2-oxoimidazolidin-1-yl)ethyl)-1H-imidazol-3-ium tetrafluoroborate (6)The solution of 1-methyl-3-(2-(3-methyl-2-oxoimidazolidin-1-yl) ethyl)-1H-imidazol-3-ium chloride (0.54 g, 2.2 mmol) in methanol (2 ml) was added to sodium tetrafluoroborate (0.24 g, 2.2 mmol). The mixture was stirred at room temperature for 24 h. The mixture was filtered and evaporated to give the title compound 6 (0.65 g, quant.) as yellow liquid.1H NMR (500 MHz, DMSO): δ = 2.60(3H, s), 3.24–3.28(4H, m), 3.47(2H, t, J=6), 3.85(3H, s), 4.30(2H, t, J=6), 7.68(1H, s), 7.75(1H, s), 9.10(1H, s). 13C-NMR(125 MHz, DMSO): δ =31.4, 36.2, 42.7, 44.7, 44.9, 47.4, 123.1, 123.9, 137.2, 161.3. HRMS (APCI): m/z [M]+ calcd for C10H17N4O, 209.1402; found: 209.13960.1-methyl-3-(2-(3-methyl-2-oxoimidazolidin-1-yl)ethyl)-1H-imidazol-3-ium hexafluorophosphate (7)The solution of 1-methyl-3-(2-(3-methyl-2-oxoimidazolidin-1-yl) ethyl)-1H-imidazol-3-ium chloride (0.75 g, 3.0 mmol) in methanol (2 ml) was added to potassium hexafluorophosphate (0.55 g, 3.0 mmol). The mixture was stirred at room temperature for 24 h. The mixture was filtered and evaporated to give the title compound 7 (1.06 g, quant.) as white solid. mp 85–102 °C.1H NMR (500 MHz, DMSO): δ = 2.60 (3H, s), 3.22–3.30 (4H, m), 3.47 (2H, t, J=6), 3.85 (3H, s), 4.29 (2H, t, J=6), 7.68 (1H, s), 7.75 (1H, s), 9.10 (1H, s). 13C-NMR (125 MHz, DMSO): δ =31.4, 36.2, 42.7, 44.7, 44.9, 47.4, 123.1, 123.9, 137.3, 161.3. HRMS (APCI): m/z [M]+ calcd for C10H17N4O, 209.1402; found: 209.13975.